Investigational Site Number : 8400001 — New York, New York

Investigational Site Number : 8400001 is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Investigational Site Number : 8400001 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion.

Sponsors: Sanofi.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Investigational Site Number : 8400001?

Investigational Site Number : 8400001 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Investigational Site Number : 8400001 conducted?

Investigational Site Number : 8400001 has 1 clinical trials on record, with 1 currently active. Their work covers Focal Segmental Glomerulosclerosis, Glomerulonephritis Minimal Lesion.

Is Investigational Site Number : 8400001 accredited by Crixeo Health?

Investigational Site Number : 8400001 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Investigational Site Number : 8400001?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.